SCHEMBL22071895

SCHEMBL22071895

C=N/C(=C\C(C)=C/C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.34
▸ TSHR P16473 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ ATM Q13315 2/20 0.31
▸ NFE2L2 Q16236 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19300441 0.81 AKT1 (0.38) LMNAMAPK1L3MBTL1HTTALDH1A1
SCHEMBL21229634 0.81 MAPT (0.43) LMNAMAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL20625867 0.81 MEN1 (0.32) LMNAMAPK1L3MBTL1HTTMEN1
SCHEMBL22036325 0.81 LMNA (0.36) LMNAMAPK1L3MBTL1HTTALDH1A1
SCHEMBL24884816 0.78 AKT1 (0.35) LMNAMAPK1L3MBTL1HTTALDH1A1
SCHEMBL20908860 0.76 MEN1 (0.32) LMNAMAPK1L3MBTL1HTTMEN1
SCHEMBL22071486 0.74 CES2 (0.34) LMNAMAPK1L3MBTL1HTTALDH1A1
SCHEMBL21390836 0.74 — —
SCHEMBL21746859 0.73 CES2 (0.33) LMNAMAPK1L3MBTL1HTTALDH1A1
SCHEMBL19101609 0.73 TSHR (0.32) LMNAMAPK1L3MBTL1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181045-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181045-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION CRY1, CRY2, NCAPH LMNA 1027/4885MAPK1 2577/4885L3MBTL1 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback